Regulated delayed expression of rfaH in an attenuated Salmonella enterica serovar typhimurium vaccine enhances immunogenicity of outer membrane proteins and a heterologous antigen.
about
Bacteria in Cancer Therapy: Renaissance of an Old ConceptEvaluation of protective efficacy of live attenuated Salmonella enterica serovar Gallinarum vaccine strains against fowl typhoid in chickens.Development of Streptococcus pneumoniae Vaccines Using Live VectorsSalmonella synthesizing 1-dephosphorylated [corrected] lipopolysaccharide exhibits low endotoxic activity while retaining its immunogenicity.Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimurium.Generation of influenza virus from avian cells infected by Salmonella carrying the viral genomePalmitoylation state impacts induction of innate and acquired immunity by the Salmonella enterica serovar typhimurium msbB mutant.Efficiency of conditionally attenuated Salmonella enterica serovar Typhimurium in bacterium-mediated tumor therapy.Phosphate groups of lipid A are essential for Salmonella enterica serovar Typhimurium virulence and affect innate and adaptive immunityAn rfaH Mutant of Salmonella enterica Serovar Typhimurium is Attenuated in Swine and Reduces Intestinal Colonization, Fecal Shedding, and Disease Severity Due to Virulent Salmonella Typhimurium.New technologies in developing recombinant attenuated Salmonella vaccine vectors.Assessment of attenuated Salmonella vaccine strains in controlling experimental Salmonella Typhimurium infection in chickens.Regulated delayed expression of rfc enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines.Salmonella enterica as a vaccine carrier.Biosynthetically engineered lipopolysaccharide as vaccine adjuvant.Optimizing Salmonella enterica serovar Typhimurium for bacteria-mediated tumor therapy.Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella Typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challengearoA-Deficient Salmonella enterica Serovar Typhimurium Is More Than a Metabolically Attenuated Mutant.O-Serotype Conversion in Salmonella Typhimurium Induces Protective Immune Responses against Invasive Non-Typhoidal Salmonella Infections.Salmonella Vaccines: Conduits for Protective Antigens.
P2860
Q26751222-7623C7A1-7E3B-4CB3-87DE-7E6EC1356E8DQ34260848-2A00802B-392A-4782-A829-4AF5E335284BQ34316015-F6AC97F2-21F1-44B6-8287-7328B2DF37D4Q35059006-81503012-3524-480D-B886-45210C619F5EQ35273125-1C164F7A-1A00-4B38-A71B-4D6BF811467AQ35572130-7031DB93-53BF-46CB-98DB-B534FD8AE72EQ35598110-33741DEA-C6D7-4217-B0E8-0966E2C3EF35Q35677522-BECD3012-217A-4624-94EB-067378E6FF4DQ36163168-6BB1687B-8CB7-4116-BE6E-22250C72BE45Q36344731-A13AFE54-B8E4-46BE-8487-5AA49424FE00Q36653379-A16365B3-B344-4F4A-8AC9-162B4FBC8100Q37425256-9C365B39-EE0B-465C-95C7-EB66C5EC9472Q37640815-572B5B86-5714-409F-9496-D7EA3A92117FQ37970705-FEBDA441-6115-4B74-8513-9E1A96F1B54AQ38386726-40DD138D-8258-4500-8580-7BE82D3EF728Q38759314-3FF5066D-B51C-4E1C-855C-55E73BC2E700Q40548549-C52A55C8-1BDD-498A-9BA5-F7D7A652F1B7Q40549367-ECA67EAF-8758-4D37-A37C-A834DCEB0416Q47103827-7E309EEC-59F5-4340-AF7E-D842DA83165DQ49644946-6BFDB085-2B3F-4DB2-90CF-90E601DE3456
P2860
Regulated delayed expression of rfaH in an attenuated Salmonella enterica serovar typhimurium vaccine enhances immunogenicity of outer membrane proteins and a heterologous antigen.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Regulated delayed expression o ...... ns and a heterologous antigen.
@en
Regulated delayed expression o ...... ns and a heterologous antigen.
@nl
type
label
Regulated delayed expression o ...... ns and a heterologous antigen.
@en
Regulated delayed expression o ...... ns and a heterologous antigen.
@nl
prefLabel
Regulated delayed expression o ...... ns and a heterologous antigen.
@en
Regulated delayed expression o ...... ns and a heterologous antigen.
@nl
P2093
P2860
P356
P1476
Regulated delayed expression o ...... ns and a heterologous antigen.
@en
P2093
Kenneth L Roland
Qingke Kong
Roy Curtiss
P2860
P304
P356
10.1128/IAI.00831-09
P407
P577
2009-10-05T00:00:00Z